have extensive pharma and diagnostic experience, be a strong leader with excellent communication and collaboration skills... experience in pharma preferred - Ability to work in highly matrixed environment & leading by influence...
pharma and diagnostic experience, be a strong leader with excellent communication and collaboration skills, and be able... - Commercial and/or access experience in pharma preferred - Ability to work in highly matrixed environment & leading by influence...
implementation of new and revised PQS documents for the site and ensure maintenance and continuous improvement of Pharma Quality... is preferred) with at least 5 years of relevant working experience in a biotech or pharmaceutical operating environment...
Market Access, Pricing and Strategic Planning Lead – Established Pharma Preferred Locations: Singapore, Singapore... and Strategic Planning Lead (MAPP) – Established Pharma: you will work with a variety of stakeholders to maximise the long-term...
and support for the regional life science ecosystem Shaping the Local Scientific Ecosystem: o Foster local academic, biotech... is required · 5-8 years of broad MedTech and/or Pharma R&D experience, preferably across multiple therapeutic areas...
the lives of people, solving complex challenges related to pharmaceutical, biotech, and animal health research... & Requirements Minimum 5 years' previous design experience. Preference will be given to candidates who have experience in pharma...
on user experience, we make our solutions the preferred choice for ambitious startups and successful market leaders in pharma... and biotech. Job Description We are looking for an individual that has the ability to work in a multi tasked fast paced...
REC stock surges 9.5% to ₹555.45 on strong Q4FY24 results, 33% YoY jump in net profit to ₹4,079 crore. Revenue grows 25% YoY. Scrip up 336% from 52-week low. Company aims to be NPA-free by FY25 with debt-raising plan of ₹1.6 lakh crore. Continue Reading »
Small-cap stock below ₹50: Gujarat Toolroom share price has been hitting the upper circuit after the company declared the date of announcement of Q4 results 2024 Continue Reading »
BofA upgrades Vodafone Idea to 'neutral', citing potential for tariff hike leverage and enhanced 4G network coverage. Despite positive outlook, BofA refrains from recommending VIL as a buy, awaiting clarity on funding post-FY26. BofA suggests that tariff revisions may occur post-general elections. Continue Reading »
Netweb Technologies India’s net profit in the fourth quarter of FY24 jumped 181.8% to ₹29.66 crore from ₹10.52 crore in the year-ago quarter. Continue Reading »
Nifty today: Shares of HDFC Bank, RIL, Infosys, TCS, and Kotak Mahindra Bank hold key as they hold around 35% weight in the 50-stock index, say experts Continue Reading »
It remains to be seen if demand is sustainable enough to absorb the increase in supply, given that interest rate cut hopes are unlikely to materialize any time soon. Continue Reading »
Stock Market Today: Coal India share price after rising 92% in a year trades flat ahead of Q4 results. While the gains for the share price have been driven by rising volumes and good e-auction premiums, what to expect during Q4 results? Continue Reading »